Agile Therapeutics, Inc. Announces that Twirla® Meets Primary Endpoint in Comparative Wear Study and Demonstrates Non-Inferior Adhesion to Xulane®
Stock Information for Agile Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.